In bladder cancer, TP53INP2 influences cell migration, invasion, and epithelial-mesenchymal transition (EMT) by regulating the GSK-3β/β-catenin/Snail1 pathway (55). This evidence concerns the gene TP53INP2 and urinary bladder carcinoma.